Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.40 |
| ▸ | FADS1 | O60427 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | GFER | P55789 | 1/20 | 0.38 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3899768 | 0.84 | ACHE (0.43) | SLC6A3MAPTGAAALDH1A1HPGD | |
| SCHEMBL3909908 | 0.84 | ACHE (0.44) | MAPTALDH1A1HPGDCYP1A2CYP3A4 | |
| SCHEMBL28049710 | 0.80 | ALDH1A1 (0.49) | MEN1KMT2AHTTLMNAMAPT | |
| SCHEMBL3900452 | 0.78 | ACHE (0.45) | MEN1KMT2ALMNAMAPTNPSR1 | |
| SCHEMBL3908589 | 0.78 | NPC1 (0.39) | SLC6A3MEN1KMT2AMAPTGAA | |
| SCHEMBL3905199 | 0.78 | SLC6A2 (0.41) | SLC6A3MEN1KMT2ALMNAMAPT | |
| SCHEMBL3895790 | 0.77 | ACHE (0.43) | SLC6A3MEN1KMT2AHPGDSMN1; SMN2 | |
| SCHEMBL3908430 | 0.77 | ACHE (0.33) | LMNAMAPTCYP1A2CYP2C19 | |
| SCHEMBL4098333 | 0.76 | ALDH1A1 (0.53) | SLC6A3MEN1KMT2AHTTLMNA | |
| SCHEMBL3902804 | 0.76 | ALDH1A1 (0.36) | HTTMAPTGAAALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090017307-A1 | Process for the Preparation of Organic Materials | MCA TECHNOLOGIES, GMBH (CH) | 2009-01-15 | — | — | US | disclosed |
| US-20080060554-A1 | Process for the Preparation of Organic Materials | MCA TECHNOLOGIES, GMBH (CH) | 2008-03-13 | — | — | US | disclosed |
| US-20070119345-A1 | Process for the preparation of organic materials | MCA TECHNOLOGIES, GMBH (CH) | 2007-05-31 | — | — | US | disclosed |
| EP-0654472-B1 | Process for the production of 6,13-dihydroquinacridones | TOYO INK MFG CO (JP) | 2000-03-29 | — | — | EP | disclosed |
| US-5610306-A | ALCOHOL ELIMINATION REACTION OF 2,5-DI(PHENYLAMINO)-3,6--DIHYDROTEREPHTHALIC ACID DIALKYL ESTER; CYCLIZATION | TOYO INK MANUFACTURING CO., LTD. (JP) | 1997-03-11 | — | — | US | disclosed |
| EP-0654472-A1 | Process for the production of 6,13-dihydroquinacridones and apparatus for use for the production | TOYO INK MANUFACTURING CO., LTD. (JP) | 1995-05-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090017307-A1 | Process for the Preparation of Organic Materials | KLK4, PDK4, GRK1 | SLC6A3 3377/4885MEN1 3197/4885KMT2A 2942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.